NCT06087887

Brief Summary

The goal of this observational study is to learn about in small bowel adenocarcinoma patients. The main question it aims to answer is the association between tumor size and prognosis in patients with small bowel adenocarcinoma. Participants will be compared for the relationship between tumor size and prognosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,163

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
Last Updated

October 18, 2023

Status Verified

October 1, 2023

Enrollment Period

8 months

First QC Date

October 11, 2023

Last Update Submit

October 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study

    We will study the relationship between tumor size and prognosis in small bowel adenocarcinoma patients in the SEER database

    2024.9.1

Study Arms (11)

tumor size 0-1cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 0-1 cm.

Other: no interventions

tumor size 1-2 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 1-2 cm.

tumor size 2-3 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 2-3 cm.

tumor size 3-4 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 3-4 cm.

tumor size 4-5 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 4-5 cm.

tumor size 5-6 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 5-6 cm.

tumor size 6-7 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 6-7 cm.

tumor size 7-8 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 7-8 cm.

tumor size 8-9 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 8-9 cm.

tumor size 9-10 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of 9-10 cm.

tumor size >10 cm

No intervention. Select small bowel adenocarcinoma patients with tumor size of \>10 cm.

Interventions

no interventions

tumor size 0-1cm

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data of Small Bowel adenocarcinoma patients from 2004 to 2019 was collected from the SEER database using the SEER\*Stat software (version 8.4.0.1).

You may qualify if:

  • pathology confirmed as SBA;
  • received surgery and complete postoperative follow-up data;
  • histology type code 8140-8380.

You may not qualify if:

  • Cases with unknown tumor location, size, TNM staging, race, and degree of differentiation were excluded. Finally, 8,163 eligible patients were included in the analysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dalian Third People's Hospital Affiliated to Dalian Medical University

Dalian, Liaoning, China

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
docter

Study Record Dates

First Submitted

October 11, 2023

First Posted

October 18, 2023

Study Start

January 1, 2023

Primary Completion

September 1, 2023

Study Completion

October 1, 2023

Last Updated

October 18, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Locations